| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |